ORIGINAL ARTICLE
Year : 2019  |  Volume : 27  |  Issue : 1  |  Page : 1-7

Evaluation of Ocular Pain During and After Intravitreal Injection of Antivascular Endothelial Growth Factors in South-West Nigeria


Department of Ophthalmology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria

Correspondence Address:
Dr. Judith G Akinwande
Department of Ophthalmology, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife
Nigeria
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/njo.njo_22_18

Rights and Permissions

Aim: This article determines pain scores during and after intravitreal injections in black Africans so as to make evidence-based decisions in pain management. Settings and Design: This was a prospective cohort study conducted over 16 months following institutional ethical clearance on adults scheduled for intravitreal antivascular endothelial growth factor (anti-VEGF) therapy. Materials and Methods: Age, sex, indication for therapy, presence of diabetes mellitus, anti-VEGF agent, current dose of anti-VEGF taken, and quadrant of injection were recorded. Pain was measured with visual analog scale during the procedure and 15 min, 30 min, 1 h, and 3 h after procedure. Pain intensity was classified into no pain, mild, moderate, and severe. Data were analyzed using Statistical Package for the Social Sciences version 22.0, P-value below 0.05 was considered statistically significant. Results: A total of 49 eyes of 49 patients with male-to-female ratio of 1.2:1 and mean age of 66.61 ± 11.24 years were studied. Most common indication for anti-VEGF was diabetic retinopathy (17, 34.7%) and most patients (34, 69.4%) received bevacizumab. The mean pain score during injection was 36.33 ± 23.25; this progressively decreased with time to 0.20 ± 1.42 by 3 h postinjection (P < 0.001). Six (12.2%) patients experienced no pain at all during the injection, whereas mean pain score was significantly higher in those who had bevacizumab injections (P = 0.031) and diabetes (P = 0.013). Pain was mainly mild in severity during the injection and female patients tended to have more severe pains. Conclusion: Pain during intravitreal anti-VEGF in black Africans is mild, and it resolves within 3 h of the injection.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed593    
    Printed73    
    Emailed0    
    PDF Downloaded188    
    Comments [Add]    

Recommend this journal